Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Research Reports

Anticoagulants Market Report 2021-26: Industry Growth, Size, Share, Trends and Forecast

Global Banking And Finance 1 News

 According to the latest report by IMARC Group, titled, “Anticoagulants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, The global anticoagulants marketexhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 10% during 2021-2026.

Blood clots form when blood thickens, forming a semi-solid mass in any part of the body. This can lead to severe health issues, such as heart attack, stroke, pulmonary embolism, transient ischemic attacks, deep vein thrombosis (DVT), etc. Owing to this, doctors prescribe anticoagulant drugs to people who are at a high risk of blood clot formation. These drugs aid in thinning blood, reducing or preventing blood clotting, and prolonging the clotting period. They are generally available in capsule or tablet form, including rivaroxaban, warfarin, dabigatran, apixaban, etc.

Get a PDF Sample for more detailed market insights: https://www.imarcgroup.com/anticoagulants-market/requestsample

Anticoagulants%2BMarket - Global Banking | Finance


Market Trends

The sudden outbreak of the COVID-19 pandemic is leading to an increasing number of individuals becoming afflicted by hypercoagulability, which is becoming one of the biggest causes of mortality across the globe. This is catalyzing the demand for anticoagulant drugs to treat this thrombotic condition in critically ill or hospitalized patients. Moreover, the rising incidences of risk factors, such as trauma, extended sitting, smoking, blood disorders, autoimmune diseases, etc., that can cause blood clotting in various body parts are also augmenting the global market. Additionally, the growing prevalence of the human immunodeficiency virus (HIV), hepatitis C, Lyme disease, obesity, cancer, chronic inflammation, etc., is further propelling the market growth. Besides this, the improving diagnosis rates and the escalating need for target therapeutics are expected to fuel the anticoagulants market over the forecasted period.


Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.


Ask Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/anticoagulants-market

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

·         Alexion Pharmaceuticals Inc

·         Aspen Holdings

·         Bayer AG

·         Boehringer Ingelheim International GmbH

·         Bristol-Myers Squibb Company

·         Daiichi Sankyo Company Limited

·         Dr. Reddy’s Laboratories Ltd

·         GlaxoSmithKline plc

·         Johnson & Johnson Private Limited

·         Pfizer Inc.

·         Sanofi.


The report has segmented the market based on drug class, route of administration, distribution channel and application.


Breakup by Drug Class:

·         Novel Oral Anticoagulants (NOACs)

·         Heparin and Low Molecular Weight Heparin (LMWH)

·         Vitamin K Antagonist

·         Others


Breakup by Route of Administration:

·         Oral Anticoagulant

·         Injectable Anticoagulant


Breakup by Distribution Channel:

·         Hospital Pharmacies

·         Retail Pharmacies

·         Online Stores

·         Others


Breakup by Application:

·         Atrial Fibrillation and Heart Attack

·         Stroke

·         Deep Vein Thrombosis (DVT)

·         Pulmonary Embolism (PE)

·         Others


Breakup by Region:

·         North America

·         Asia-Pacific

·         Europe

·         Latin America

·         Middle East and Africa


Browse Other Reports:

 

·         Data Wrangling Market- https://www.imarcgroup.com/data-wrangling-market

·         Alopecia Treatment Market- https://www.imarcgroup.com/alopecia-treatment-market

·         Anti-Rheumatics Market- https://www.imarcgroup.com/anti-rheumatics-market

·         Push-to-Talk Over Cellular Market- https://www.imarcgroup.com/push-to-talk-over-cellular-market

·         Auto Dimming Mirror Market- https://www.imarcgroup.com/auto-dimming-mirror-market

·         Algae Products Market- https://www.imarcgroup.com/algae-products-market

·         Security Testing Market- https://www.imarcgroup.com/security-testing-market

·         Microbiome Sequencing Services Market- https://www.imarcgroup.com/microbiome-sequencing-services-market

·         Ablation Devices Market- https://www.imarcgroup.com/ablation-devices-market

·         Anticoagulants Market- https://www.imarcgroup.com/anticoagulants-market

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

30 N Gould St
Ste R
Sheridan, WY 82801
USA
Email: [email protected]
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post